Paragon 28 (NYSE:FNA – Get Free Report) is projected to issue its quarterly earnings data before the market opens on Thursday, March 6th. Analysts expect the company to announce earnings of ($0.12) per share and revenue of $70.81 million for the quarter.
Paragon 28 Trading Down 0.3 %
NYSE FNA opened at $13.00 on Wednesday. The company has a quick ratio of 1.60, a current ratio of 3.50 and a debt-to-equity ratio of 0.79. The firm has a market cap of $1.09 billion, a PE ratio of -17.56 and a beta of 1.54. The company has a 50 day moving average price of $11.90 and a 200 day moving average price of $9.25. Paragon 28 has a 52 week low of $4.65 and a 52 week high of $13.13.
Wall Street Analyst Weigh In
A number of research analysts have issued reports on the stock. Canaccord Genuity Group set a $13.00 price target on shares of Paragon 28 in a research note on Wednesday, January 29th. Stephens restated an “equal weight” rating and set a $13.00 price target (down previously from $14.00) on shares of Paragon 28 in a research note on Thursday, January 30th. William Blair lowered shares of Paragon 28 from an “outperform” rating to a “market perform” rating in a research note on Wednesday, January 29th. Finally, Needham & Company LLC restated a “hold” rating and set a $13.00 price target on shares of Paragon 28 in a research note on Wednesday, January 29th. Four research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $14.20.
Insider Transactions at Paragon 28
In other news, major shareholder Mvm Partners, Llc sold 27,142 shares of the stock in a transaction on Monday, January 27th. The shares were sold at an average price of $11.62, for a total value of $315,390.04. Following the sale, the insider now owns 10,313,841 shares in the company, valued at $119,846,832.42. This represents a 0.26 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 15.32% of the company’s stock.
About Paragon 28
Paragon 28, Inc develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems.
See Also
- Five stocks we like better than Paragon 28
- What is a buyback in stocks? A comprehensive guide for investors
- GitLab: Get In While It’s Down—Big Rebound Ahead
- Why Invest in High-Yield Dividend Stocks?
- Tesla Stock: Finding a Bottom May Take Time
- What Makes a Stock a Good Dividend Stock?
- Duolingo: This Beaten-Down Stock Is About to Rally 38%
Receive News & Ratings for Paragon 28 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Paragon 28 and related companies with MarketBeat.com's FREE daily email newsletter.